Metsera, A Wholly Owned Subsidiary Of Pfizer

This study is testing whether combining two experimental drugs (MET233 and MET097) can help people with obesity or overweight lose weight safely. About 132 adults will receive either the drug combination or a placebo. The main goal is to check for side effects and see how the dru…

This study tests a new once-weekly injection called MET097 for weight loss in adults with obesity or overweight who also have related health issues like high blood pressure. About 3,500 participants will receive the shot or a placebo for up to 84 weeks. The goal is to see how muc…